PAI
EW icon

Palo Alto Investors’s Edwards Lifesciences EW Stock Holding History

Palo Alto Investors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.69M Hold
33,640
– – 0.41% 33
2025
Q4 		$2.87M Hold
33,640
– – 0.4% 33
2025
Q3 		$2.62M Sell
33,640
-5,833
-15% -$456K 0.48% 31
2025
Q2 		$3.09M Hold
39,473
– – 0.66% 24
2025
Q1 		$2.86M Hold
39,473
– – 0.54% 24
2024
Q4 		$2.92M Hold
39,473
– – 0.45% 24
2024
Q3 		$2.6M Buy
+39,473
New +$2.87M 0.34% 27

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Palo Alto Investors's EW Position: Q1 2026 in Review

Palo Alto Investors held its Edwards Lifesciences (EW) position steady in Q1 2026 at 33,640 shares worth $2.69M. The position accounts for 0.41% of the portfolio, ranked #33.

Palo Alto Investors first reported a position in EW in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.09M in Q2 2025. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Palo Alto Investors held 33,640 shares of Edwards Lifesciences worth $2.69M as of Q1 2026.
  • Palo Alto Investors left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.41% of Palo Alto Investors's portfolio in Q1 2026, its #33 holding.
  • Palo Alto Investors first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 7 quarters since.
  • Palo Alto Investors's Edwards Lifesciences position peaked at $3.09M in Q2 2025.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Palo Alto Investors's 13F filing for Q1 2026, filed 15 May 2026.